ACCORD HEALTHCARE LIMITED
Location
Founded
2004-04-13
Risk Signals
337 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Medicinal Chemicals and Botanical Products, Pharmaceutical Preparations, Drugs, Drug Proprietaries, and Druggists' Sundries), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about ACCORD HEALTHCARE LIMITED
Live alerts from global media, monitored by Business Radar
2025-02-05 (mortgagestrategy.co.uk)
Accord extends £5k deposit mortgage, TSB trims rates –
Accord Mortgages has extended the eligibility criteria for its £5k deposit mortgage to make it available to those purchasing a flat, while TSB announces rate increases and cuts of up to 0.10%. Accord launched its original £5k deposit mortgage in March last year. It enables first-time buyers with a £5,000 deposit to
Read more
2025-02-01 (prnewswire.co.uk)
Accord Healthcare launches Disulfiram in the United Kingdom, indicated as a supportive agent in the treatment of alcoholism
/PRNewswire/ -- Accord Healthcare UK Ltd announces that following launch to wholesalers in Dec 2024, the alcohol deterrent compound Disulfiram (the active...
Read more
2024-06-14 (forbes.com)
Mortgage News: TSB, Coventry Adjust Rates
Find out what's happening with mortgage rates today and calculate monthly repayments across a range of different rates and deals. 14 June: Borrowers
Read more
2024-06-13 (forbes.com)
Mortgage News: Clydesdale Increases Rates For Low-Deposit Borrowers
Find out what's happening with mortgage rates today and calculate monthly repayments across a range of different rates and deals. 13 June: FCA Says
Read more
2024-06-06 (forbes.com)
Mortgage News: TSB, Skipton Raise Rates As Hopes Fade For June Bank Rate Cut
Find out what's happening with mortgage rates today and calculate monthly repayments across a range of different rates and deals. 6 June: Lenders Fo
Read more
2024-05-24 (forbes.com)
Mortgage News: Coventry Joins Rate-Cutters
Find out what's happening with mortgage rates today and calculate monthly repayments across a range of different rates and deals. 24 May: Society Un
Read more
2024-05-22 (forbes.com)
Mortgage News: Halifax, Santander Cut Fixed Rates In Wake Of Inflation Decrease
Find out what's happening with mortgage rates today and calculate monthly repayments across a range of different rates and deals. 22 May: More Lende
Read more
2024-05-20 (forbes.com)
Mortgage News: HSBC Trims Fixed Rates
Find out what's happening with mortgage rates today and calculate monthly repayments across a range of different rates and deals. 20 May: Tumbling I
Read more
2024-05-10 (forbes.com)
Mortgage News: TSB First Lender To Respond To Bank Rate Hold With Price Cuts
We have a suite of mortgage calculators to help you work out how repayments will affect your household finances, what you could save by remortgaging, and t
Read more
2023-10-11 (prnewswire.co.uk)
Accord Healthcare launches Accord Animal Health
/PRNewswire/ -- Accord Healthcare, one of the fastest-growing pharmaceutical companies in Europe, committed to providing high-quality medicines at the point of...
Read more
2023-06-23 (pharmaphorum.com)
Accord launches app to help cancer patients manage symptoms
Accord Healthcare has introduced a new app in the UK designed to help people undergoing treatment for cancer maintain their physical and mental wellbeing.The Unify Health app helps patients understand their illness, track symptoms and treatment progress, receive tips on health habits and importantly
Read more
2023-04-07 (pharmaphorum.com)
Accord’s biosimilar Pelgraz poised for approval
Cancer biosimilar drug Pelgraz is poised to hit the market after receiving a positive opinion by the Committee for Medicinal Products for Human Use (CHMP).Accord Healthcare’s Pelgraz could become the first pegfilgrastim biosimilar to be launched in Europe once it is fully approved by regulators.
Read more